Credit Suisse’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$13M Sell
129,566
-9,622
-7% -$846K 0.01% 802
2023
Q4
$12.5M Buy
139,188
+583
+0.4% +$46.5K 0.01% 826
2023
Q3
$10.6M Sell
138,605
-26,413
-16% -$2.19M 0.01% 875
2023
Q2
$13.8M Buy
165,018
+213
+0.1% +$17.3K 0.01% 784
2023
Q1
$13.9M Sell
164,805
-15,954
-9% -$1.37M 0.01% 803
2022
Q4
$14.7M Buy
180,759
+43,730
+32% +$3.52M 0.02% 766
2022
Q3
$9.74M Buy
137,029
+14,122
+11% +$1.27M 0.01% 914
2022
Q2
$11M Sell
122,907
-10,446
-8% -$1.08M 0.01% 899
2022
Q1
$14.9M Buy
133,353
+3,323
+3% +$389K 0.01% 876
2021
Q4
$15.7M Sell
130,030
-7,305
-5% -$812K 0.01% 1214
2021
Q3
$13.8M Sell
137,335
-13,048
-9% -$1.44M 0.01% 1321
2021
Q2
$17.5M Sell
150,383
-81,712
-35% -$9.81M 0.01% 1214
2021
Q1
$25.6M Buy
232,095
+5,150
+2% +$559K 0.01% 1032
2020
Q4
$22.8M Sell
226,945
-102,118
-31% -$9.47M 0.01% 1098
2020
Q3
$25.7M Buy
329,063
+45,398
+16% +$3.42M 0.02% 897
2020
Q2
$19.8M Buy
283,665
+6,330
+2% +$399K 0.01% 957
2020
Q1
$12.9M Sell
277,335
-90,502
-25% -$5.81M 0.01% 1051
2019
Q4
$29.2M Sell
367,837
-26,640
-7% -$2.05M 0.02% 821
2019
Q3
$29.1M Sell
394,477
-13,424
-3% -$963K 0.02% 712
2019
Q2
$31.7M Sell
407,901
-125,406
-24% -$9.53M 0.03% 669
2019
Q1
$40.5M Buy
533,307
+273,811
+106% +$21.8M 0.04% 501
2018
Q4
$19M Buy
259,496
+16,098
+7% +$1.28M 0.02% 817
2018
Q3
$23.3M Buy
243,398
+902
+0.4% +$89.4K 0.02% 791
2018
Q2
$24.2M Sell
242,496
-31,151
-11% -$3.29M 0.02% 735
2018
Q1
$28.9M Sell
273,647
-213,539
-44% -$21.6M 0.03% 661
2017
Q4
$45.1M Buy
487,186
+43,413
+10% +$3.94M 0.04% 477
2017
Q3
$40.2M Sell
443,773
-394
-0.1% -$33.5K 0.04% 494
2017
Q2
$37.3M Sell
444,167
-22,191
-5% -$1.79M 0.04% 517
2017
Q1
$37.7M Sell
466,358
-193,511
-29% -$15.2M 0.03% 533
2016
Q4
$49.6M Sell
659,869
-772,892
-54% -$55.8M 0.05% 405
2016
Q3
$97M Buy
1,432,761
+947,720
+195% +$63.6M 0.09% 215
2016
Q2
$32.9M Buy
485,041
+49,064
+11% +$3.61M 0.04% 544
2016
Q1
$31.5M Buy
435,977
+49,402
+13% +$3.24M 0.04% 527
2015
Q4
$26.1M Buy
386,575
+42,782
+12% +$2.99M 0.03% 638
2015
Q3
$22.3M Sell
343,793
-10,888
-3% -$804K 0.03% 677
2015
Q2
$29M Buy
354,681
+1,366
+0.4% +$105K 0.03% 640
2015
Q1
$24.5M Buy
353,315
+51,757
+17% +$3.74M 0.02% 719
2014
Q4
$22.9M Sell
301,558
-9,691
-3% -$766K 0.02% 813
2014
Q3
$25.2M Sell
311,249
-5,101
-2% -$426K 0.02% 806
2014
Q2
$27.6M Buy
316,350
+87,653
+38% +$7.62M 0.02% 763
2014
Q1
$19.7M Sell
228,697
-144,607
-39% -$11.9M 0.02% 848
2013
Q4
$30.1M Buy
373,304
+84,494
+29% +$6.56M 0.03% 624
2013
Q3
$22.5M Sell
288,810
-115,054
-28% -$8.86M 0.02% 683
2013
Q2
$28.3M Buy
+403,864
New +$28.2M 0.03% 599

Other funds holding EMN

Credit Suisse's EMN Position: Q1 2024 in Review

Credit Suisse reduced its Eastman Chemical (EMN) stake by 6.9% in Q1 2024, selling an estimated $846K and leaving 129,566 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #802.

Credit Suisse first reported a position in EMN in Q2 2013 and has held it in 44 quarters since. The position peaked at $97M in Q3 2016. 747 funds tracked by Wall St. Rank hold EMN as of Q1 2024.

  • Credit Suisse held 129,566 shares of Eastman Chemical worth $13M as of Q1 2024.
  • Credit Suisse sold 9,622 Eastman Chemical shares in Q1 2024, an estimated $846K.
  • Eastman Chemical made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #802 holding.
  • Credit Suisse first reported a position in Eastman Chemical in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Eastman Chemical position peaked at $97M in Q3 2016.
  • 747 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.